Supplemental material
Open access
4,300
Views
3
CrossRef citations to date
0
Altmetric
Reports
Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody
Sharon M. Campbella Biomedicine Design, Pfizer, Dublin, Ireland
, Joseph DeBartolob Biomedicine Design, Pfizer, Cambridge, MA, USA
, James R. Apgarb Biomedicine Design, Pfizer, Cambridge, MA, USA
, Lydia Mosyakb Biomedicine Design, Pfizer, Cambridge, MA, USA
, Virginie McManusa Biomedicine Design, Pfizer, Dublin, Ireland
, Sonia Beyera Biomedicine Design, Pfizer, Dublin, Ireland
, Eric M. Bennettb Biomedicine Design, Pfizer, Cambridge, MA, USA
, Matthew Lamberta Biomedicine Design, Pfizer, Dublin, Ireland
& Orla Cunninghama Biomedicine Design, Pfizer, Dublin, IrelandCorrespondence[email protected]
https://orcid.org/0000-0002-3888-9541
show allhttps://orcid.org/0000-0002-3888-9541
Article: 1883239
|
Received 02 Dec 2020, Accepted 26 Jan 2021, Published online: 09 Feb 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.